T cell-selective deletion of Oct1 protects animals from autoimmune neuroinflammation while maintaining neurotropic pathogen response.
Heejoo KimLaura DickeyColleen StoneJillian L JafekThomas E LaneDean TantinPublished in: Journal of neuroinflammation (2019)
Our findings uncover a significant difference between the effect of Oct1 loss on autoimmune and anti-pathogen responses, which potentially could be exploited for therapeutic benefit.